Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 248.00
+12.42 (5.27%)
Jul 10, 2026, 3:30 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 21.37 billion as of July 10, 2026. Its market cap has increased by 256.35% in one year.
Market Cap
21.37B
Enterprise Value
17.16B
Revenue
6.41B
Ranking
n/a
PE Ratio
50.92
Stock Price
248.00
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 21.37B, an increase of 19,062.80%. That is a compound annual growth rate of 21.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 21.37B | 197.04% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aarti Pharmalabs | 63.73B |
| Innova Captab | 56.70B |
| Orchid Pharma | 53.30B |
| RPG Life Sciences | 43.94B |
| Solara Active Pharma Sciences | 27.31B |
| Indoco Remedies | 23.55B |
| Beta Drugs | 22.11B |
| Sakar Healthcare | 17.81B |